Mirogabalin

DB11825InvestigationalSmall molecule

Mirogabalin has been used in trials studying the treatment of Post-herpetic Neuralgia, Pain Associated With Fibromyalgia, and Diabetic peripheral neuropathic pain.

Chemical structure of Mirogabalin
Mechanism
Curator reviewed
Formula / weight
C12H19NO2 · 209.289 g/mol (avg)
Code names
A200-0700

Resolves to

Compound
UNIIS7LK2KDM5UCAS1138245-13-2ChEMBLCHEMBL3545125ChEBI755472PubChem59509752
Clinical / RWD
ATCN02BF03
Structure
InChIKeyFTBQORVNHOIASH-CKYFFXLPSA-NSMILESCCC1=C[C@@H]2[C@@H](C[C@]2(CN)CC(O)=O)C1
Targets
P54289CACNA2D1Q9NY47CACNA2D2

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
13Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mirogabalin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In